Meisner Lara (CIK 1883986) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-01). Recent activity: Buy BCAX (33,807 shares), Sell BCAX (33,807 shares), Buy BCAX (15,829 shares), Sell BCAX (15,829 shares), Buy BCAX (15,829 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-01 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Buy | 33,807 | $312,377 |
| 2025-10-01 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Sell | 33,807 | $498,653 |
| 2025-09-17 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Buy | 15,829 | $86,268 |
| 2025-09-17 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Sell | 15,829 | $181,875 |
| 2025-06-18 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Buy | 15,829 | $86,268 |
| 2025-06-18 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Sell | 15,829 | $165,096 |
| 2025-03-18 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Buy | 79,146 | $431,346 |
| 2025-03-18 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Sell | 48,526 | $615,795 |
| 2025-03-18 | Bicara Therapeutics Inc. (BCAX) | Chief Legal Officer | Sell | 30,620 | $405,409 |
Source: SEC Form 4 filings · as of 2025-10-01